3 結果
TECHNICAL FIELD
The present disclosure pertains to the fields of neurology and medicine. More particularly, the present disclosure relates to biomarkers, kits comprising the biomarkers and their use for detecting and/or diagnosing the occurrence of ischemic stroke events.
BACKGROUND
Ischemic stroke
BACKGROUND OF THE INVENTION
1. Technical Field
The present invention relates to compositions for and a method of treatment of neuronal degeneration due to stroke, brain, retina or spinal cord injuries and other brain or retinal disorders by glucocorticoids or glutamine synthetase.
2. Background
This invention relates to novel peptides of the alpha conotoxin (.alpha.-conotoxin) class and their use in the treatment or prevention of pain, in recovery from nerve injury and in the treatment of painful neurological conditions such as stroke. The invention also relates to pharmaceutical